Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features.
作者： Fiamma Buttitta , Fabio Barassi , Giuseppina Fresu , Lara Felicioni , Antonio Chella
DOI: 10.1002/IJC.22143
关键词:
摘要: … on HER2 mutations in lung tumors were carried out mainly on East Asian patients.28, 30 The frequency of HER2 mutations in European lung … of HER2 mutations in a large series of lung …
sci-hub.se 参考文章(37)
Shinichi Toyooka, Katsuyuki Kiura, Tetsuya Mitsudomi, None, EGFR mutation and response of lung cancer to gefitinib. The New England Journal of Medicine. ,vol. 352, pp. 2136- ,(2005) , 10.1056/NEJM200505193522019
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Vincent A. Pollack, Catherine DiOrio, April Theleman, Elsa G. Barbacci, Leslie R. Pustilnik, Mark Neveu, Mikel P. Moyer, Kenneth K. Iwata, Lee Arnold, Michael J. Morin, James D. Moyer, Bruce Boman, Penny Miller, Ann Cunningham, Margaret M. Reynolds, Don Sloan, Jonathan Doty, Induction of Apoptosis and Cell Cycle Arrest by CP-358,774, an Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinase Cancer Research. ,vol. 57, pp. 4838- 4848 ,(1997)
Antonio Marchetti, Buttitta F, Giorgio Merlo, Francesca Diella, Silvia Pellegrini, Pepe S, Paolo Macchiarini, Antonio Chella, C Alberto Angeletti, Robert Callahan, Maria Bistocchi, Francesco Squartini, p53 Alterations in Non-Small Cell Lung Cancers Correlate with Metastatic Involvement of Hilar and Mediastinal Lymph Nodes Cancer Research. ,vol. 53, pp. 2846- 2851 ,(1993)
Silvano Bosari, Fiamma Buttitta, Guido Coggi, Barbara Cassani, Massimo Roncalli, Monica Falleni, Monica Miozzo, Caterina Pellegrini, Antonio Marchetti, HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry. Clinical Cancer Research. ,vol. 9, pp. 3645- 3652 ,(2003)
R M Hudziak, G D Lewis, M Winget, B M Fendly, H M Shepard, A Ullrich, p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Molecular and Cellular Biology. ,vol. 9, pp. 1165- 1172 ,(1989) , 10.1128/MCB.9.3.1165
Mustafa Erman, Dominique Grunenwald, Frederique Penault-Llorca, Julien Grenier, Benjamin Besse, Pierre Validire, Luc Morat, Philippe Girard, Thierry Le Chevalier, Laure Sabatier, Jean-Charles Soria, Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features. Lung Cancer. ,vol. 47, pp. 315- 323 ,(2005) , 10.1016/J.LUNGCAN.2004.08.015
Adi F. Gazdar, Hisayuki Shigematsu, Joachim Herz, John D. Minna, Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers? Trends in Molecular Medicine. ,vol. 10, pp. 481- 486 ,(2004) , 10.1016/J.MOLMED.2004.08.008
Fred R Hirsch, Corey J Langer, The role of HER2/neu expression and trastuzumab in non-small cell lung cancer Seminars in Oncology. ,vol. 31, pp. 75- 82 ,(2004) , 10.1053/J.SEMINONCOL.2003.12.018
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938